IDEXX beats expectations on Q2 earnings, but cuts full-year outlook further

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted second-quarter results that exceeded market expectations while again cutting its full-year financial outlook, citing macroeconomic risks and other headwinds.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water testing reported Q2 earnings of $1.56 per share, beating the $1.54 per share consensus estimate of analysts polled by Zacks Investment Research. That compares to earnings per share of $2.34 a year ago. Read more

Related Posts

UNE undergraduate receives BioME grant to study rare lobster larvae

A University of New England undergraduate student has received a $5,000 grant from the Bioscience Association of Maine (BioME) to fund...

23 May 2024

New initiative unites Maine’s innovators to bolster STEM research and workforce

An $8 million grant from the National Science Foundation will fund a four-year initiative led by the University of Maine to bolster STEM...

15 May 2024

Jackson Lab hires its first-ever chief scientific officer

Jackson Laboratory, based in Bar Harbor, has hired Mary Dickinson, a globally recognized geneticist, developmental biologist, and bioengineer, as executive vice...

13 May 2024